Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial status update on exogenous ketone supplements in patients hospitalized for acute heart failure, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exogenous ketone supplements (exogenous ketones)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Acute Heart Failure (AHF) | Phase 2 | Status: RECRUITING